Literature DB >> 28442557

High phosphate induces a pro-inflammatory response by vascular smooth muscle cells and modulation by vitamin D derivatives.

Julio M Martínez-Moreno1,2,3, Carmen Herencia4, Addy Montes de Oca1,2,3, Juan M Díaz-Tocados1,2,3, Noemi Vergara1,2,3, M José Gómez-Luna1,2,3, Silvia D López-Argüello5, Antonio Camargo1,3,6,7, Esther Peralbo-Santaella1,2,3, Maria E Rodríguez-Ortiz8, Antonio Canalejo9, Mariano Rodríguez1,3,10,11, Juan R Muñoz-Castañeda12,3,10,11, Yolanda Almadén1,3,6,7.   

Abstract

In chronic kidney disease patients, high phosphate (HP) levels are associated with cardiovascular disease, the major cause of morbidity and mortality. Since serum phosphate has been independently correlated with inflammation, the present study aimed to investigate an independent direct effect of HP as a pro-inflammatory factor in VSMCs. A possible modulatory effect of vitamin D (VitD) was also investigated. The study was performed in an in vitro model of human aortic smooth muscle cells (HASMCs). Incubation of cells in an HP (3.3 mM) medium caused an increased expression of the pro-inflammatory mediators intercellular adhesion molecule 1 (ICAM-1), interleukins (ILs) IL-1β, IL-6, IL-8 and tumour necrosis factor α (TNF-α) (not corroborated at the protein levels for ICAM-1), as well as an increase in reactive oxygen/nitrogen species (ROS/RNS) production. This was accompanied by the activation of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signalling as demonstrated by the increase in the nuclear translocation of nuclear factor κ-light-chain-enhancer of activated B cells protein 65 (p65-NF-κΒ) assessed by Western blotting and confocal microscopy. Since all these events were attenuated by an antioxidant pre-incubation with the radical scavenger Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), it is suggested that the inflammatory response is upstream mediated by the ROS/RNS-induced activation of NF-κΒ. Addition of paricalcitol (PC) 3·10-8 M to cells in HP prevented the phosphate induced ROS/RNS increase, the activation of NF-κΒ and the cytokine up-regulation. A bimodal effect was observed, however, for different calcitriol (CTR) concentrations, 10-10 and 10-12 M attenuated but 10-8 M stimulated this phosphate induced pro-oxidative and pro-inflammatory response. Therefore, these findings provide novel mechanisms whereby HP may directly favour vascular dysfunctions and new insights into the protective effects exerted by VitD derivatives.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Calcitriol; Inflammation; Oxidative stress; Paricalcitol; Phosphate; VSMCs

Mesh:

Substances:

Year:  2017        PMID: 28442557     DOI: 10.1042/CS20160807

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

1.  A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects.

Authors:  Jaber Mohammad; Roberto Scanni; Lukas Bestmann; Henry N Hulter; Reto Krapf
Journal:  J Am Soc Nephrol       Date:  2018-07-18       Impact factor: 10.121

Review 2.  The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy.

Authors:  Stelian Adrian Ritiu; Alexandru Florin Rogobete; Dorel Sandesc; Ovidiu Horea Bedreag; Marius Papurica; Sonia Elena Popovici; Daiana Toma; Robert Iulian Ivascu; Raluca Velovan; Dragos Nicolae Garofil; Dan Corneci; Lavinia Melania Bratu; Elena Mihaela Pahontu; Adriana Pistol
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

Review 3.  Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.

Authors:  Peter Stenvinkel; Johanna Painer; Makoto Kuro-O; Miguel Lanaspa; Walter Arnold; Thomas Ruf; Paul G Shiels; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2018-01-15       Impact factor: 28.314

4.  Effect of Synbiotic and Probiotic Supplementation on Serum Levels of Endothelial Cell Adhesion Molecules in Hemodialysis Patients: a Randomized Control Study.

Authors:  Neda Haghighat; Majid Mohammadshahi; Shokouh Shayanpour; Mohammad Hossein Haghighizadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

5.  Role of vitamin D in the pathogenesis of atheromatosis.

Authors:  Erika Rimondi; Annalisa Marcuzzi; Fabio Casciano; Gianluca Tornese; Agnese Pellati; Barbara Toffoli; Paola Secchiero; Elisabetta Melloni
Journal:  Nutr Metab Cardiovasc Dis       Date:  2020-09-12       Impact factor: 4.222

6.  Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study.

Authors:  Shunsuke Yamada; Masanori Tokumoto; Masatomo Taniguchi; Hisako Yoshida; Hokuto Arase; Narihito Tatsumoto; Hideki Hirakata; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

Review 7.  Strategies for Phosphate Control in Patients With CKD.

Authors:  Fellype Carvalho Barreto; Daniela Veit Barreto; Ziad A Massy; Tilman B Drüeke
Journal:  Kidney Int Rep       Date:  2019-06-20

8.  Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease.

Authors:  Vaia Raikou; Vasilios Kardalinos; Despina Kyriaki
Journal:  J Cardiovasc Dev Dis       Date:  2018-06-21

Review 9.  Molecular mechanisms and genetic regulation in atherosclerosis.

Authors:  Ampadu-Okyere Jackson; Mugwaneza Annick Regine; Chakrabarti Subrata; Shiyin Long
Journal:  Int J Cardiol Heart Vasc       Date:  2018-09-25

10.  Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms.

Authors:  Rafael Santamaría; Juan M Díaz-Tocados; M Victoria Pendón-Ruiz de Mier; Ana Robles; M Dolores Salmerón-Rodríguez; Erena Ruiz; Noemi Vergara; Escolástico Aguilera-Tejero; Ana Raya; Rosa Ortega; Arnold Felsenfeld; Juan R Muñoz-Castañeda; Alejandro Martín-Malo; Pedro Aljama; Mariano Rodríguez
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.